TNNI3 and cancer: Biomarkers including cTnI and natriuretic peptide, echocardiography measurements including global longitudinal strain, and cardiac MRI are considered significant methods for screening cancer patients, indicating myocardial damage with high sensitivity [80,81,82,83].